India needs innovative strategies to eliminate TB

Source: The post “India needs innovative strategies to eliminate TB” has been created based on “India needs innovative strategies to eliminate TB”, published in “The Hindu” on 6 June 2026. India needs innovative strategies to eliminate TB.

UPSC Syllabus: GS-2- Governance

Context: Tuberculosis (TB) remains one of the deadliest infectious diseases in the world and continues to pose a major public health challenge in India. Despite advances in treatment, India carries one of the highest TB burdens globally, making TB elimination a national priority.

Challenges in Eliminating TB in India

1. Absence of a highly effective vaccine

1. The century-old BCG vaccine primarily protects against severe childhood forms of TB and does not provide reliable protection against pulmonary TB in adults.
2. Therefore, a highly effective universal TB vaccine is still unavailable.

2. Large disease burden

1. India accounts for a significant share of the global TB burden.
2. The high incidence of TB creates pressure on the healthcare system and complicates elimination efforts.

3. Presence of latent TB infection

1. A large number of individuals carry latent TB infection without symptoms.
2. These individuals may later develop active TB, making detection and prevention difficult.

4. Extra-pulmonary TB burden

5. A substantial proportion of TB cases in India involve extra-pulmonary TB, which affects organs other than the lungs.
6. These cases are often harder to diagnose and manage.
7. Social and nutritional vulnerabilities: Undernutrition, poverty, overcrowding, and poor living conditions increase susceptibility to TB and negatively affect treatment outcomes.
8. Co-morbidities and vulnerable populations: Individuals with conditions such as HIV, diabetes, and weakened immunity face a greater risk of developing active TB and experiencing severe disease.
9. Delays in diagnosis and treatment: Many TB cases remain undetected or are diagnosed late, allowing continued transmission within communities.

Reasons for Innovative Strategies for India

1. Expansion of advanced diagnostics

1. India has made progress through the deployment of molecular diagnostic tools such as TruNat.
2. These technologies enable faster and more accurate detection of TB cases.

2. Adoption of preventive treatment: Preventive therapy for individuals with latent TB infection can significantly reduce progression to active disease and lower transmission rates.
3. Targeted vaccination approach

4. Evidence from the VPM1002 vaccine trial suggests that targeted vaccination of high-risk groups may offer meaningful protection.
5. Such groups include household contacts of TB patients, school-age children, adolescents, and vulnerable adults.
6. Community-based screening: Active case finding and screening among high-risk populations can help identify cases earlier and reduce disease spread.
7. Nutritional support interventions: Nutritional assistance can improve immunity, treatment adherence, and recovery among TB patients, particularly those suffering from undernutrition.
8. Integration with public health programmes: TB control efforts should be integrated with programmes addressing malnutrition, HIV, diabetes, and primary healthcare to achieve better outcomes.
9. Evidence-based policy making: India should adopt interventions that have demonstrated measurable public health benefits instead of waiting solely for future technological breakthroughs.

Role of New Vaccine Research

1. Potential of VPM1002

1. The VPM1002 vaccine has shown encouraging results in reducing pulmonary and extra-pulmonary TB in high-risk populations.
2. It may become an important tool in India’s TB control strategy if further evidence supports its effectiveness.

2. Complementary rather than standalone solution

1. Even if new vaccines prove successful, vaccination alone cannot eliminate TB.
2. Vaccines must be combined with prevention, early diagnosis, treatment, and social support measures.

Way Forward

1. Shift from passive to active case finding: India should move beyond waiting for symptomatic patients to approach health facilities and instead undertake community-based screening, household contact tracing, and targeted surveillance in high-burden areas.
2. Scale up preventive treatment for latent TB: Preventive therapy should be expanded for household contacts of TB patients, healthcare workers, immunocompromised individuals, and other high-risk groups to reduce progression from latent infection to active disease.
3. Strengthen molecular diagnostic infrastructure: Rapid diagnostic tools such as TruNat and other molecular tests should be made universally accessible, particularly in rural and underserved areas, to ensure early and accurate detection.
4. Adopt targeted vaccination strategies: Evidence-based deployment of promising vaccines such as VPM1002 should be considered for vulnerable populations, including household contacts of TB patients, school-age children, adolescents, and individuals with comorbidities.
5. Integrate nutrition with TB care: Nutritional support should be treated as a core component of TB management because undernutrition remains a major risk factor for both disease progression and poor treatment outcomes.
6. Leverage digital technologies and data analytics: Digital platforms should be used for case notification, treatment monitoring, contact tracing, adherence support, and real-time surveillance to improve programme efficiency.
7. Address social determinants of TB: Efforts to improve housing conditions, sanitation, living standards, and access to healthcare should complement medical interventions, as TB is closely linked to poverty and social deprivation.
8. Enhance public-private collaboration: Since a large number of patients seek treatment in the private sector, stronger integration of private healthcare providers into the National TB Elimination Programme is necessary for comprehensive case detection and reporting.
9. Increase investment in research and innovation: Greater support should be provided for vaccine development, diagnostic technologies, drug research, and operational studies to identify context-specific solutions for India.
10. Adopt a multi-sectoral “Whole-of-Society” approach: The fight against TB should involve governments, healthcare institutions, educational establishments, civil society organizations, local communities, and international partners to ensure sustained progress toward elimination.

Conclusion: India’s TB elimination goal cannot be achieved through a single intervention. A combination of early diagnosis, preventive treatment, targeted vaccination, nutritional support, and strong public health systems is essential. A comprehensive and evidence-based strategy offers the best pathway toward a TB-free India.

Question: India’s goal of eliminating tuberculosis (TB) requires moving beyond the search for a perfect vaccine.” Discuss the challenges in TB elimination and evaluate the role of innovative strategies in achieving India’s TB-free target.

Source: The Hindu